LOCALLY RECURRENT PROSTATE CANCER
Clinical trials for LOCALLY RECURRENT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCALLY RECURRENT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for LOCALLY RECURRENT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
MRI-Guided radiation: a sharper weapon against prostate cancer?
Disease control Recruiting nowThis study tests a new way to deliver high-dose radiation to prostate tumors using real-time MRI guidance. It includes two groups: men whose prostate cancer has returned after prior radiation, and men with advanced cancer receiving standard external beam radiation plus this boost…
Matched conditions: LOCALLY RECURRENT PROSTATE CANCER
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Tiny Alpha-Ray seeds aim to zap recurrent prostate cancer
Disease control Recruiting nowThis study tests whether a new type of radiation seed, called DaRT, can be safely placed inside the prostate to treat cancer that has returned after initial treatment. Up to 10 men with non-metastatic, locally recurrent prostate cancer will receive the seeds. The main goal is to …
Matched conditions: LOCALLY RECURRENT PROSTATE CANCER
Phase: NA • Sponsor: Alpha Tau Medical LTD. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Second chance: focused radiation for recurrent prostate cancer
Disease control Recruiting nowThis early-phase trial is testing whether a second, highly targeted dose of radiation (SBRT) can safely treat prostate cancer that has returned after initial radiation therapy. The study involves 36 men whose cancer is confined to a small area of the prostate. The main goal is to…
Matched conditions: LOCALLY RECURRENT PROSTATE CANCER
Phase: NA • Sponsor: Royal North Shore Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC